Skip to main content
Log in

Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients

  • Research Article
  • Published:
Genes & Genomics Aims and scope Submit manuscript

Abstract

Background

Glycogen storage disease type III is an autosomal recessive disorder that is caused by deficiencies of the glycogen debranching enzyme. Mutations within the AGL gene have been found to be heterogeneous, with some common mutations being reported in certain populations. The mutation spectrum of AGL gene in the multi-ethnic Malaysian population is still unknown.

Objective

The present study seeks to determine the mutation spectrum of the AGL gene in Malaysian population.

Methods

A total of eleven patients (eight Malay, two Chinese and one Bajau) were investigated. Genomic DNA was extracted and subsequently the AGL gene was amplified using specific primers and sequenced. Mutations found were screened in 150 healthy control samples either by restriction enzyme digestion assay or TaqMan® SNP Genotyping assay.

Results

We identified six unreported mutations (c.1423+1G>T, c.2914_2915delAA, c.3814_3815delAG, c.4333T>G, c.4490G>A, c.4531_4534delTGTC) along with three previously reported mutations (c.99C>T, c.1783C>T, c.2681+1G>A). One of the six unreported mutation causes abnormal splicing and results in retention of intron 12 of the mature transcript, while another is a termination read-through. One of the reported mutation c.2681+1G>A was recurrently found in the Malay patients (n = 7 alleles; 31.8%).

Conclusion

The mutation spectrum of the AGL gene in Malaysian patients has shown considerable heterogeneity, and all unreported mutations were absent in all 150 healthy control samples tested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aoyama Y, Ozer I, Demirkol M, Ebara T, Murase T, Podskarbi T, Shin YS, Gokcay G, Okubo M (2009) Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p. R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations. J Hum Genet 54:681–686

    Article  CAS  PubMed  Google Scholar 

  • Cheng A, Zhang M, Okubo M, Omichi K, Saltiel AR (2009) Distinct mutation in the glycogen debranching enzyme found in glycogen storage disease type III lead to impairment in diverse cellular functions. Hum Mol Genet 18:2045–2052

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116(11):896–900

    Article  CAS  PubMed  Google Scholar 

  • Goldstein JL, Austin SL, Boyette K, Kanaly A, Veerapandiyan A, Rehder C, Kishnani PS, Bali DS (2010) Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with glycogen storage disease type III. Genet Med 12:424–430

    Article  CAS  PubMed  Google Scholar 

  • Hadjigeorgiou GM, Comi GP, Bordoni A, Shen J, Chen YT, Salani S, Toscano A, Fortunato F, Lucchiari S, Bresolin N et al (1999) Novel donor splice site mutations of AGL gene in glycogen storage disease type IIIa. J Inherit Metab Dis 22:762–763

    Article  CAS  PubMed  Google Scholar 

  • Hendriksz CJ, Gissen P (2014) Glycogen storage disease. J Paediatr Child Health 25(3):139–144

    Article  Google Scholar 

  • Hofhuis J, Schueren F, Nötzel C, Thomas L, Gärtner J, Jahn O, Thoms S (2016) The functional read-through extension of malate dehydrogenase reveals a modification of the genetic code. Open Biol 6:160246

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ko JS, Moon JS, Seo JK, Yang HR, Chang JY, Park SS (2013) A mutation analysis of the AGL gene in Korean patients with glycogen storage disease type III. J Hum Genet 59(1):42–45

    Article  CAS  PubMed  Google Scholar 

  • Lam CW, Lee ATC, Lam YY, Wong TW, Mak TWL, Fung WC, Chan KC, Ho CS, Tong SF (2004) DNA-based subtyping of glycogen storage disease type III: mutation and haplotype analysis of the AGL gene in Chinese. Mol Genet Metab 83:271–275

    Article  CAS  PubMed  Google Scholar 

  • Okubo M, Horinishi A, Nakamura N, Aoyama Y, Hashimoto M, Endo Y, Murase T (1998) A novel point mutation in an acceptor splice site of intron 32 (IVS32 A−12 → G) but no exon 3 mutations in the glycogen debranching enzyme gene in a homozygous patient with glycogen storage disease type IIIb. J Hum Genet 102:1–5

    Article  CAS  Google Scholar 

  • Okubo M, Kanda F, Horinishi A, Takahashi K, Okuda S, Kazuo C, Murase T (1999) Glycogen storage disease type IIIa: first report of a causative missense mutation (G1448R) of the glycogen debranching enzyme gene found in a homozygous patient. Hum Mutat 14:542–543

    Article  CAS  PubMed  Google Scholar 

  • Okubo M, Horinishi A, Takeuchi M, Suzuki Y, Sakura N, Hasegawa Y, Igarashi T, Goto K, Tahara H, Uchimoto S et al (2000) Heterogenous mutation in the glycogen debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan. J Hum Genet 106:108–115

    Article  CAS  Google Scholar 

  • Santer R, Kinner M, Steuerwald U, Kjærgaard S, Skovby F, Simonsen H, Shaiu WL, Chen YT, Schneppenheim R, Schaub J (2001) Molecular genetic basis and prevalence of glycogen storage disease type IIIa in the Faroe Islands. Eur J Hum Genet 9:388–391

    Article  CAS  PubMed  Google Scholar 

  • Schueren F, Lingner T, George R, Hofhuis J, Dickel C, Gärtner J, Thoms S (2014) Peroxisomal lactate dehydrogenase is generated by translational read-through in mammals. eLife 3:e03640

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shaiu WL, Kishnani PS, Shen J, Liu HM, Chen Y-T (2000) Genotype-phenotype correlation in two frequent mutation update in type III glycogen storage disease. Mol Genet Metab 69:16–23

    Article  CAS  PubMed  Google Scholar 

  • Shen JJ, Chen YT (2002) Molecular characterization of glycogen storage disease type III. Curr Mol Med 2:167–175

    Article  CAS  PubMed  Google Scholar 

  • Shen J, Bao Y, Chen YT (1997) A nonsense mutation due to a single base insertion in the 3´-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa. Hum Mutat 9:37–40

    Article  CAS  PubMed  Google Scholar 

  • Van Hoof F, Hers HG (1967) The subgroups of type III glycogenosis. Eur J Biochem 2:265–270

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank University Malaya Medical Centre and Kuala Lumpur Hospital for providing blood samples or DNA samples of GSD III patients; Dr Heng Hock Sin for providing clinical data of patient 11; Assoc. Prof. Dr. Ng Ching Ching and Dr. Azlina Ahmad Annuar for providing DNA samples for population study; Centre for Research in Biotechnology for Agriculture (CEBAR), UM for contributing the sequencing platform. Lastly, we thank Ministry of Science, Technology and Innovation of Malaysia for the eScience fund (SF012-2012) and University of Malaya for the UM Biotechnology and Bioproduct Research Cluster fund (RG071-12BIO).

Funding

This study was funded by eScience fund (SF012-2012) and UM Biotechnology and Bioproduct Research Cluster fund (RG071-12BIO).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zulqarnain Mohamed.

Ethics declarations

Conflict of interest

Ser-Huy Teh, Fiqri Dizar Khaidizar, Lock-Hock Ngu, Wee-Teik Keng, Sufin Yap, Zulqarnain Mohamed, and author declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This project was approved by the Medical Ethics Committee University Malaya Medical Centre reference number: UMMC MEC 2012/908.27.

Informed consent

Written informed consent was obtained for all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdullah, I.S., Teh, SH., Khaidizar, F.D. et al. Intron retention is among six unreported AGL mutations identified in Malaysian GSD III patients. Genes Genom 41, 885–893 (2019). https://doi.org/10.1007/s13258-019-00815-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13258-019-00815-9

Keywords

Navigation